n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride has been researched along with naxagolide in 1 studies
Studies (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Trials (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Recent Studies (post-2010) (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Studies (naxagolide) | Trials (naxagolide) | Recent Studies (post-2010) (naxagolide) |
---|---|---|---|---|---|
67 | 0 | 0 | 159 | 8 | 49 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, AM; Starr, MS | 1 |
1 other study(ies) available for n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride and naxagolide
Article | Year |
---|---|
Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.
Topics: Animals; Benzazepines; Dopamine D2 Receptor Antagonists; Epilepsy; Ergolines; Evoked Potentials; Female; Gyrus Cinguli; In Vitro Techniques; Lisuride; Magnesium; Male; Oxazines; Phenethylamines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrahydronaphthalenes | 1994 |